PRLD
Prelude Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website reludetx.com
- Employees(FY) 128
- ISIN US74065P1012
Performance
-1.72%
1W
-18.53%
1M
-13.61%
3M
+17.65%
6M
-6.32%
YTD
-36.51%
1Y
Profile
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Technical Analysis of PRLD 2024-05-10
Overview:
In analyzing the technical indicators for PRLD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...
Recent News & Updates
- 2024-05-08 19:01
- 2024-05-07 01:53
- 2024-05-06 19:01
- 2024-04-09 04:35
- 2024-03-05 03:45
- 2024-02-29 03:05
- 2024-02-15 03:05
- 2023-12-10 20:34
Prelude Therapeutics Announces $25 Million Private Placement(Globenewswire)
- 2023-11-02 20:42
Q3 2023 Abcellera Biologics Inc Earnings Call(Yahoo Finance)
- 2023-11-02 17:55
- 2023-11-01 04:10
- 2023-11-01 04:05
- 2023-10-14 00:30
- 2023-10-04 00:00
- 2023-08-28 20:30
- 2023-08-16 21:56
10 Healthcare Stocks with Insider Buying(Yahoo Finance)
- 2023-08-02 20:00
- 2023-07-09 20:13
- 2023-06-01 23:36
- 2023-05-30 20:30
- 2023-05-27 20:11
- 2023-05-17 19:00
Prelude Therapeutics Announces Pricing of Public Offering(Yahoo Finance)
- 2023-05-17 04:08
- 2023-05-07 20:30
- 2023-04-26 20:30
- 2023-04-10 20:30
- 2023-04-06 21:34
- 2023-03-18 06:48
The 7 Worst Stocks to Buy Now(Yahoo Finance)
- 2023-03-16 00:06
- 2023-03-14 20:30
Page 1 of 4
previousnext